Literature DB >> 22940000

Adenosine and autism: a spectrum of opportunities.

Susan A Masino1, Masahito Kawamura, Jessica L Cote, Rebecca B Williams, David N Ruskin.   

Abstract

In rodents, insufficient adenosine produces behavioral and physiological symptoms consistent with several comorbidities of autism. In rodents and humans, stimuli postulated to increase adenosine can ameliorate these comorbidities. Because adenosine is a broad homeostatic regulator of cell function and nervous system activity, increasing adenosine's influence might be a new therapeutic target for autism with multiple beneficial effects. This article is part of the Special Issue entitled 'Neurodevelopmental Disorders'.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22940000      PMCID: PMC3529135          DOI: 10.1016/j.neuropharm.2012.08.013

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  100 in total

Review 1.  History of the ketogenic diet.

Authors:  James W Wheless
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

2.  Visual abilities and sensory differences in a person with autism.

Authors:  Temple Grandin
Journal:  Biol Psychiatry       Date:  2009-01-01       Impact factor: 13.382

Review 3.  Purinergic signalling: from normal behaviour to pathological brain function.

Authors:  Geoffrey Burnstock; Ute Krügel; Maria P Abbracchio; Peter Illes
Journal:  Prog Neurobiol       Date:  2011-09-01       Impact factor: 11.685

4.  Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity.

Authors:  Ditte Lovatt; Qiwu Xu; Wei Liu; Takahiro Takano; Nathan A Smith; Jurgen Schnermann; Kim Tieu; Maiken Nedergaard
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-15       Impact factor: 11.205

5.  The EL mouse: a natural model of autism and epilepsy.

Authors:  Joshua J Meidenbauer; John G Mantis; Thomas N Seyfried
Journal:  Epilepsia       Date:  2011-01-04       Impact factor: 5.864

6.  Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor.

Authors:  B Johansson; L Halldner; T V Dunwiddie; S A Masino; W Poelchen; L Giménez-Llort; R M Escorihuela; A Fernández-Teruel; Z Wiesenfeld-Hallin; X J Xu; A Hårdemark; C Betsholtz; E Herlenius; B B Fredholm
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

7.  Notes on the history of caffeine use.

Authors:  Bertil B Fredholm
Journal:  Handb Exp Pharmacol       Date:  2011

8.  The relationship between the neuromodulator adenosine and behavioral symptoms of autism.

Authors:  Susan A Masino; Masahito Kawamura; Louisa M Plotkin; Julia Svedova; Francis J DiMario; Inge-Marie Eigsti
Journal:  Neurosci Lett       Date:  2011-06-15       Impact factor: 3.046

9.  Noise induces A1 adenosine receptor expression in the chinchilla cochlea.

Authors:  Vickram Ramkumar; Craig A Whitworth; Sandeep C Pingle; Larry F Hughes; Leonard P Rybak
Journal:  Hear Res       Date:  2004-02       Impact factor: 3.208

10.  Endogenous adenosine modulates epileptiform activity in rat hippocampus in a receptor subtype-dependent manner.

Authors:  Lori-An V Etherington; Bruno G Frenguelli
Journal:  Eur J Neurosci       Date:  2004-05       Impact factor: 3.386

View more
  14 in total

Review 1.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

Review 2.  Purinergic system in psychiatric diseases.

Authors:  A Cheffer; A R G Castillo; J Corrêa-Velloso; M C B Gonçalves; Y Naaldijk; I C Nascimento; G Burnstock; H Ulrich
Journal:  Mol Psychiatry       Date:  2017-09-26       Impact factor: 15.992

3.  Developmental role of adenosine kinase for the expression of sex-dependent neuropsychiatric behavior.

Authors:  D M Osborne; U S Sandau; A T Jones; J W Vander Velden; A M Weingarten; N Etesami; Y Huo; H Y Shen; D Boison
Journal:  Neuropharmacology       Date:  2018-08-23       Impact factor: 5.250

Review 4.  Adenosine receptors and epilepsy: current evidence and future potential.

Authors:  Susan A Masino; Masahito Kawamura; David N Ruskin
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

5.  Analysis of Extracellular Nucleotide Metabolism in Adult Zebrafish After Embryological Exposure to Valproic Acid.

Authors:  Fernanda Francine Zimmermann; Karina Vidarte Gaspary; Anna Maria Siebel; Carlos Eduardo Leite; Luiza Wilges Kist; Mauricio Reis Bogo; Carla Denise Bonan
Journal:  Mol Neurobiol       Date:  2016-05-17       Impact factor: 5.590

6.  Developmental Role of Adenosine Kinase in the Cerebellum.

Authors:  Hoda Gebril; Amir Wahba; Xiaofeng Zhou; Tho Lai; Enmar Alharfoush; Emanuel DiCicco-Bloom; Detlev Boison
Journal:  eNeuro       Date:  2021-06-02

Review 7.  Adenosine kinase: An epigenetic modulator in development and disease.

Authors:  Madhuvika Murugan; Denise Fedele; David Millner; Enmar Alharfoush; Geetasravya Vegunta; Detlev Boison
Journal:  Neurochem Int       Date:  2021-05-05       Impact factor: 4.297

8.  Ketogenic diet improves behaviors in a maternal immune activation model of autism spectrum disorder.

Authors:  David N Ruskin; Michelle I Murphy; Sierra L Slade; Susan A Masino
Journal:  PLoS One       Date:  2017-02-06       Impact factor: 3.240

9.  Ketogenic diet improves core symptoms of autism in BTBR mice.

Authors:  David N Ruskin; Julia Svedova; Jessica L Cote; Ursula Sandau; Jong M Rho; Masahito Kawamura; Detlev Boison; Susan A Masino
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

10.  GWAS and transcriptional analysis prioritize ITPR1 and CNTN4 for a serum uric acid 3p26 QTL in Mexican Americans.

Authors:  Geetha Chittoor; Jack W Kent; Marcio Almeida; Sobha Puppala; Vidya S Farook; Shelley A Cole; Karin Haack; Harald H H Göring; Jean W MacCluer; Joanne E Curran; Melanie A Carless; Matthew P Johnson; Eric K Moses; Laura Almasy; Michael C Mahaney; Donna M Lehman; Ravindranath Duggirala; Anthony G Comuzzie; John Blangero; Venkata Saroja Voruganti
Journal:  BMC Genomics       Date:  2016-04-02       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.